Lv11
100 积分 2025-05-16 加入
Rational design of the linkers in targeting chimeras
3小时前
已完结
Context Matters: E3 Ligase-Ligand Pairing Strategies for Optimized PROTAC Performance
4小时前
已完结
Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging Applications
4小时前
已完结
Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors
4小时前
已完结
Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation
4小时前
已完结
A multicenter, open-label phase Ib/II study of cadonilimab (anti PD-1 and CTLA-4 bispecific antibody) monotherapy in previously treated advanced non-small-cell lung cancer (AK104-202 study)
4小时前
已完结
CAR-T therapy in solid tumors
4小时前
已完结
A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
4小时前
已完结
Mesothelin-targeted CAR-T cell therapy for solid tumors
4小时前
已完结
皖公网安备34019202002308
